Friends: Thank you for joining us, Dr. Wandwalo. While there has been progress over the last 15 years, tuberculosis (TB) is still the world’s leading infectious disease killer. What would you say have been the greatest challenges in the fight against TB?
Donor government disbursements to combat HIV in low- and middle-income countries increased 16 percent from US$7 billion in 2016 to US$8.1 billion in 2017 – though the higher total stems largely from the timing of U.S.
On 28 August 2017 (Window 3), Swaziland submitted a TB/HIV funding request to the Global Fund. The total request was for $93.8 million. When broken down, $47.2 million of this amount was within the country’s allocation, $1.5 million was a matching funds request for catalytic funding to prevent HIV among adolescent girls and young women (AGYW), and $45.1 million was a prioritized above allocation request (PAAR).
In funding requests submitted to the Global Fund in Window 1 (20 March 2017) and Window 2 (23 May 2017), more than $100 million was proposed for adolescent girls and young women (AGYW). This calculation includes both allocation amounts and matching funds. In addition, more than $50 million was proposed for AGYW in prioritized above allocation requests.
Tanzania has requested $703.4 million from the Global Fund for its HIV, TB and malaria programs as well as for building resilient and sustainable systems for health (RSSH). The country submitted an integrated TB/HIV funding request as well as a malaria/RSSH request, both on 23 May 2017. The TB/HIV funding request was for $426.3 million, of which $38.4 million was a prioritized above allocation request (PAAR).
“A Quarter for Prevention”: Study finds Global Fund investments in HIV prevention in Africa fall short
Kenya’s TB/HIV funding request to the Global Fund zeros in on HIV prevention among key populations and on finding missing TB cases
Kenya was among the 35 countries that submitted funding requests to the Global Fund in Window 2 on 23 May 2017. Kenya’s TB/HIV funding request was for $421.9 million, made up of a $256.4 million allocation request, $138.9 million prioritized above-allocation request (PAAR) and a $26.6 million matching funds request. A $112.0 million malaria funding request was submitted on the same day ($60.1 million within allocation and $51.9 million PAAR).
On 23 May 2017, Zambia submitted both TB/HIV and malaria funding requests, together worth just over $400 million. The TB/HIV funding request was for $306.8 million, of which $194.4 million constituted a within-allocation request, with a further $112.4 million as a prioritized above-allocation request (PAAR).